Before prescribing controlled substances, check both state authority and federal registration requirements. An APRN should establish the correct arrangement before prescribing, rather than treating a DEA number as a general national permission.
Begin with the work: where you will practice, which activities you will perform and whether you will act under an individual or qualifying institutional arrangement.
Confirm state authority first
DEA explains that registration relies on the practitioner's authority under the laws of the relevant state. The federal registration does not independently authorize unrestricted prescribing across the country.
Check your prescriptive authority, including applicable controlled-substance schedules and conditions. Ask the state regulator and DEA registration staff to resolve uncertainties about the proposed work.
Keep the state and federal records separate so that a change or expiration in one is not overlooked.
Determine the correct registration arrangement
Federal rules contain exceptions as well as the general registration requirement. Under 21 CFR 1301.22(c), a qualifying practitioner employed by a hospital or institution may act under its registration when all listed conditions are met.
Those conditions include state authorization, institutional verification and approval, acting within the employment role, and an assigned internal code. Employment alone does not establish that the exception applies.
Ask the organization to explain and document the arrangement. Do not borrow another practitioner's registration or assume that the same permission covers unrelated work outside the institution.
Review every practice location
Section 1301.12 generally requires separate registration for principal practice locations, but includes a limited exception for certain offices in the same state where controlled substances are prescribed without being regularly administered, otherwise dispensed or stored.
Describe the actual activities at each site when seeking guidance. A statement that you work for one employer does not, by itself, settle the location question.
When moving or adding another state, review the registration and state-authority requirements before the new work begins. Remote prescribing requires its own current legal assessment.
Address the one-time training condition
Current federal rules require qualifying practitioners to satisfy the training condition beginning with their first applicable registration or renewal on or after June 27, 2023.
DEA describes ways to satisfy it, including qualifying substance-use-disorder training totaling at least eight hours and certain qualifying recent educational preparation. Check the route that actually applies; graduating from an APRN program does not alone prove the curriculum met the requirement.
Retain supporting records for the attestation. The federal condition is one-time, while separate state or certification education obligations may recur.
Distinguish this from the former X-waiver
The federal DATA-waiver, commonly called the X-waiver, was eliminated in December 2022. That change is separate from the later training condition and does not remove the other rules governing controlled substances.
Use current DEA materials rather than an old checklist requiring an X-waiver application.
Before starting a role, record who is responsible for registrations, updates, renewal reminders and prescribing-system access. Verify that the final arrangement matches your actual duties and locations, and reassess it when those change.
Sources
- DEA: Registration questions (accessed 2026-09-17).
- 21 CFR Part 1301 (accessed 2026-09-17) — §§1301.11, 1301.12 and 1301.22.
- DEA: MATE Act questions (accessed 2026-09-17).